Aprea Therapeutics
APRE
APRE
50 hedge funds and large institutions have $468M invested in Aprea Therapeutics in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less capital invested
Capital invested by funds: $591M → $468M (-$123M)
Holders
50
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$30.7M | |
| 2 | +$2.37M | |
| 3 | +$1.81M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$1.67M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.33M |
Top Sellers
| 1 | -$20M | |
| 2 | -$7.79M | |
| 3 | -$688K | |
| 4 |
Morgan Stanley
New York
|
-$439K |
| 5 |
Millennium Management
New York
|
-$291K |